Vezatin regulates seizures by controlling AMPAR-mediated synaptic activity

Area of Science:

• Neuroscience
• Epilepsy Research
• Synaptic Plasticity

Background:

• Epilepsy mechanisms remain incompletely understood, necessitating further investigation.
• Vezatin, a synaptic regulatory protein, is implicated in neuronal synaptic transmission (NST), but its role in epilepsy is unexplored.

Purpose of the Study:

• To investigate the role of vezatin in epilepsy.
• To elucidate the molecular mechanisms by which vezatin influences seizure activity.

Main Methods:

• Vezatin expression analysis in pilocarpine-induced epileptic mice and an in vitro seizure model.
• Vezatin knockdown experiments in vivo and in vitro.
• Assessment of AMPA receptor (AMPAR) function, GluA1 subunit expression, and phosphorylation.
• Inhibition of protein kinase A (PKA) phosphorylation using H-89.
• Analysis of vezatin expression in human temporal lobe epilepsy (TLE) tissues.

Main Results:

• Vezatin expression was elevated in epileptic mouse models and human TLE tissues.
• Vezatin knockdown reduced seizure activity and suppressed AMPAR-mediated synaptic events.
• Vezatin knockdown decreased GluA1 surface expression and its phosphorylation at serine 845.
• Inhibition of PKA phosphorylation blocked the effects of vezatin knockdown on GluA1.

Conclusions:

• Vezatin expression is abnormally regulated in epilepsy.
• Vezatin modulates seizure activity via AMPAR-mediated NST and GluA1 surface expression, involving PKA-mediated phosphorylation.
• Vezatin represents a potential novel therapeutic target for epilepsy.